PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Study explains control of cell metabolism in patient response to breast cancer drugs

Researchers identify a control mechanism for glutamine uptake in breast cancer cells and its importance for response to select chemotherapies

2015-03-11
(Press-News.org) La Jolla, Calif., March 9, 2015 - Researchers at Sanford-Burnham Medical Research Institute (Sanford-Burnham) have discovered a mechanism that explains why some breast cancer tumors respond to specific chemotherapies and others do not. The findings highlight the level of glutamine, an essential nutrient for cancer development, as a determinant of breast cancer response to select anticancer therapies, and identify a marker associated with glutamine uptake, for potential prognosis and stratification of breast cancer therapy.

"Our study indicates that a protein called RNF5 determines breast cancer response to paclitaxel, one of the most common chemotherapy drugs," said Ze'ev Ronai, Ph.D., scientific director of Sanford-Burnham's La Jolla campus. "Paclitaxel belongs to a class of drugs called taxanes that work by triggering a stress response in cells that in turn promotes an interaction between RNF5 and glutamine uptake proteins. We found that this interaction causes degradation of the glutamine carrier proteins, leading to an insufficient supply of glutamine and the sensitization of breast cancer tumors to death."

The study results were published in today's online edition of Cancer Cell.

For some time researchers have known that many tumor cell types are dependent on glutamine for growth and survival, but didn't know how glutamine uptake was regulated. The new findings demonstrate the importance of RNF5 in the control of glutamine uptake, and in antagonizing tumor development. The findings also suggest that testing tumors for RNF5 and glutamine carrier protein levels, such as SLC1A5, may be used to identify patients best suited to taxanes-based therapy.

"Not all tumors are equipped to respond to paclitaxel therapy," said Ronai. "Using a cohort of more than 500 breast cancer patient samples, we found that only 30 percent of tumors exhibit high levels of RNF5 and low levels of glutamine carrier proteins--the optimal profile for response to paclitaxel."

"Understanding these types of cell mechanisms and tumor characteristics that determine the response to anticancer drugs can lead to better patient stratification as well as improved therapy approaches," said Gordon Mills, M.D., Ph.D., chairman of the Department of Systems Biology at MD Anderson Cancer Center, 2013 recipient of the Susan B. Komen Brinker Award for contributions to breast cancer research, and co-author of the study. "The opportunity to identify and target key pathways involved in the behavior of breast cancer cells has the potential to both increase efficacy and decrease toxicity of therapy."

"We also used this patient cohort to test the predictive value of measuring levels of glutamine carrier proteins as a prognostic marker," said Ronai. Our results indicate that these proteins are an outstanding marker of patient outcome, as good as currently used markers."

"We have started screening for inhibitors of glutamine carrier proteins as a potential new target for breast cancer treatment," said Ronai, who is also examining the mechanism for glutamine control in other tumor types.

INFORMATION:

The study was performed in collaboration with the Departments of Pathology, Yale University; the Department of Pathology, UC Davis and the Department of Systems Biology, MD Anderson Cancer Center.

This study was funded by NIH grants CA097105, CA128814, and P30 CA30199.

About Sanford-Burnham Medical Research Institute Sanford-Burnham Medical Research Institute is dedicated to discovering the fundamental molecular causes of disease and devising the innovative therapies of tomorrow. Sanford-Burnham takes a collaborative approach to medical research with major programs in cancer, neurodegeneration and stem cells, diabetes, and infectious, inflammatory, and childhood diseases. The Institute is recognized for its National Cancer Institute-designated Cancer Center, its NIH-designated Neuroscience Center Cores, and expertise in drug discovery technologies. Sanford-Burnham is a nonprofit, independent institute that employs more than 1,000 scientists and staff in San Diego (La Jolla), Calif., and Orlando (Lake Nona), Fla. For more information, visit us at sanfordburnham.org.

Sanford-Burnham can also be found on Facebook at facebook.com/sanfordburnham and on Twitter @sanfordburnham.



ELSE PRESS RELEASES FROM THIS DATE:

Naproxen plus acid-blocking drug shows promise in preventing bladder cancer

2015-03-11
ANN ARBOR, Mich. -- The anti-inflammatory class of drugs NSAIDs have shown great promise in preventing cancers including colon, esophagus and skin. However, they can increase the risks of heart attacks, ulcers and rare but potentially life-threatening bleeds. A new study suggests there may be ways to reduce these dangerous side effects. Collaborators from the University of Michigan, the National Cancer Institute and the University of Alabama looked at naproxen, which is known to have a lower cardiovascular risk than other NSAIDs. Naproxen, like most NSAIDs and aspirin, ...

Deadly to cancer cells only

2015-03-11
Parvoviruses are a class of viruses that normally infect rodents; in humans, they do not cause any disease symptoms. However, they are able to infect and kill cancer cells. The details behind this biological selectivity on the part of the viruses have not been understood until now. "Since the viruses might soon play a role in cancer medicine, it is important to know why they replicate exclusively in tumor cells in humans," says virologist Dr. Jürg Nüesch from the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ). In order to complete their ...

New genetic evidence resolves origins of modern Japanese

2015-03-11
Was there a single migration event or gradual mixing of cultures that gave rise to modern Japanese? According to current theory, about 2,000-3,000 years ago, two populations, the hunter-gatherer Jomon from the Japanese archipelago, and the agricultural Yayoi from continental East Asia, intermingled to give rise to the modern Japanese population. However, some researchers have suggested otherwise, with the Jomon culture gradually transformed into the Yayoi culture without large migrations into modern day Japan. To resolve the controversy, researchers Oota, Mano, Nakagome ...

Stem cells in the brain: Limited self-renewal

2015-03-11
The generation of neurons (neurogenesis) in humans is predominantly limited to development; in the adult stage it takes place in only a few regions of the brain. These regions contain neural stem cells that generate neurons in a process with various intermediary stages. Stem cell renewal is limited - total number drops Until now it was thought that maintaining the stem cell pool was based on the self-renewal of individual stem cells. The team of scientists headed by Dr. Jovica Ninkovic and Professor Dr. Magdalena Götz were able to refute this: Both the self-renewal ...

It's sound -- Bristol Pound encourages community unity

2015-03-11
There is a rapidly growing momentum driving the development of mobile payment systems. New research has shown systems, such as the Bristol Pound, can have a positive effect on the local community by encouraging consumers to support and value their local businesses. The paper, which will be presented at this month's ACM Conference on Computer-Supported Cooperative Work and Social Computing (ACM CSCW 2015) [14-18 March], looks at user interactions and practices around mobile payment systems. The research, led by Dr Mark Perry at Brunel University London and visiting ...

Palm tree Coco de mer performs 'parental care' and modifies its habitat

2015-03-11
Tourists are familiar with the Lodoicea maldivica palm, also called coco de mer, mainly because of their bizarrely shaped fruits. Scientists, however, are fascinated by the huge plants - which are abundant on the Seychelles islands of Praslin and Curieuse - for entirely different reasons. The coco de mer palm engages in a lot of effort for reproduction, producing large amounts of pollen and huge fruits that cannot be spread around, but rather fall to the ground at the base. "This is nan enormous commitment of energy in very nutrient-poor soil - it does not really make ...

DNA-directed RNA transcription may have profound adaptability

2015-03-11
The central dogma of molecular biology describes the flow of genetic information. It was first described by Francis Crick in 1956 as one-way traffic: as: "DNA makes RNA and RNA makes protein." A recent paper published in Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, however suggests that, rather than being a one-way street, DNA-directed RNA transcription may have profound adaptability. The authors of the paper showed a conceptually novel relationship between the genotype (DNA) and the phenotype (the products of the transcription of DNA). The ...

Brain processes ongoing pain more emotionally

2015-03-11
This news release is available in German. A momentary lapse of concentration is all it takes for a finger to become trapped or sprain an ankle - and it hurts. Pain is the body's protective mechanism and a complex neurological phenomenon. Moreover, ongoing pain in the sense of chronic pain can be a disease. Scientists from Technische Universität München (TUM) have now demonstrated that already during a few minutes of ongoing pain, the underlying brain activity changes by shifting from sensory to emotional processes. In their experiments, Prof. Markus Ploner, ...

How changes in body weight affect the human metabolism

2015-03-11
Until now there have been few molecular epidemiological studies regarding the effects of weight changes on metabolism in the general population. In a recent study conducted and funded within the framework of the Competence Network Obesity, researchers at the Institute of Epidemiology II at Helmholtz Zentrum München (HMGU) evaluated molecular data of the KORA study*. "Techniques such as metabolomics and transcriptomics allow the simultaneous determination of a variety of low molecular weight metabolites or gene activities (transcripts of genes) using high-throughput ...

Religion and support for birth control health coverage can mix

2015-03-11
ANN ARBOR, Mich. -- New research debunks the assumption that a woman's religion predicts her views on policies affecting reproductive health care such as insurance coverage for birth control. Even when it comes to policies that have sometimes been characterized as going against Christian views - such as the Affordable Care Act mandate for employer-provided contraception coverage- religious women's opinions are mixed, finds the nationally-representative study by the University of Michigan . Protestants and Catholics were most likely to agree that employer health plans ...

LAST 30 PRESS RELEASES:

New study sheds light on Milky Way's mysterious chemical history

Could altering the daily timing of immunotherapy improve survival in people with cancer?

Weaving secondary battery electrodes with fibers and tying them like ropes for both durability and performance

Using social media may impair children’s attention

Science briefing: An update on GLP-1 drugs for obesity

Lower doses of immunotherapy for skin cancer give better results

Why didn’t the senior citizen cross the road? Slower crossings may help people with reduced mobility

ASH 2025: Study suggests that a virtual program focusing on diet and exercise can help reduce side effects of lymphoma treatment

A sound defense: Noisy pupae puff away potential predators

Azacitidine–venetoclax combination outperforms standard care in acute myeloid leukemia patients eligible for intensive chemotherapy

Adding epcoritamab to standard second-line therapy improves follicular lymphoma outcomes

New findings support a chemo-free approach for treating Ph+ ALL

Non-covalent btki pirtobrutinib shows promise as frontline therapy for CLL/SLL

University of Cincinnati experts present research at annual hematology event

ASH 2025: Antibody therapy eradicates traces of multiple myeloma in preliminary trial

ASH 2025: AI uncovers how DNA architecture failures trigger blood cancer

ASH 2025: New study shows that patients can safely receive stem cell transplants from mismatched, unrelated donors

Protective regimen allows successful stem cell transplant even without close genetic match between donor and recipient

Continuous and fixed-duration treatments result in similar outcomes for CLL

Measurable residual disease shows strong potential as an early indicator of survival in patients with acute myeloid leukemia

Chemotherapy and radiation are comparable as pre-transplant conditioning for patients with b-acute lymphoblastic leukemia who have no measurable residual disease

Roughly one-third of families with children being treated for leukemia struggle to pay living expenses

Quality improvement project results in increased screening and treatment for iron deficiency in pregnancy

IV iron improves survival, increases hemoglobin in hospitalized patients with iron-deficiency anemia and an acute infection

Black patients with acute myeloid leukemia are younger at diagnosis and experience poorer survival outcomes than White patients

Emergency departments fall short on delivering timely treatment for sickle cell pain

Study shows no clear evidence of harm from hydroxyurea use during pregnancy

Long-term outlook is positive for most after hematopoietic cell transplant for sickle cell disease

Study offers real-world data on commercial implementation of gene therapies for sickle cell disease and beta thalassemia

Early results suggest exa-cel gene therapy works well in children

[Press-News.org] Study explains control of cell metabolism in patient response to breast cancer drugs
Researchers identify a control mechanism for glutamine uptake in breast cancer cells and its importance for response to select chemotherapies